Xiaorong Li, Haoxin Guo, Zhaoxiong Wang, Zetong Nie, Xiang Zhang, Kuan Wang, Naxin Duan, Siqiong Bai, Wenbo Li, Bojie Hu
Journal: Frontiers in endocrinology 2023;14():1196335
PMID: 37693349
PURPOSE
We aimed to evaluate the risk factors and develop a prognostic nomogram of long-term low vision after diabetic vitrectomy.
METHODS
This retrospective study included 186 patients (250 eyes) that underwent primary vitrectomy for proliferative diabetic retinopathy with a minimum follow-up period of one year. Patients were assigned to the training cohort (200 eyes) or validation cohort (50 eyes) at a 4:1 ratio randomly. Based on a cutoff value of 0.3 in best-corrected visual acuity (BCVA) measurement, the training cohort was separated into groups with or without low vision. Univariate and multivariate logistic regression analyses were performed on preoperative systemic and ocular characteristics to develop a risk prediction model and nomogram. The calibration curve and the area under the receiver operating characteristic curves (AUC) were used to evaluate the calibration and discrimination of the model. The nomogram was internally validated using the bootstrapping method, and it was further verified in an external cohort.
RESULTS
Four independent risk factors were selected by stepwise forward regression, including tractional retinal detachment (β=1.443, OR=4.235, P<0.001), symptom duration ≥6 months (β=0.954, OR=2.595, P=0.004), preoperative BCVA measurement (β=0.540, OR=1.716, P=0.033), and hypertension (β=0.645, OR=1.905, P=0.044). AUC values of 0.764 (95% CI: 0.699-0.829) in the training cohort and 0.755 (95% CI: 0.619-0.891) in the validation cohort indicated the good predictive ability of the model.
CONCLUSION
The prognostic nomogram established in this study is useful for predicting long-term low vision after diabetic vitrectomy.
Copyright © 2023 Guo, Wang, Nie, Zhang, Wang, Duan, Bai, Li, Li and Hu.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.